{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:31:45Z","timestamp":1791919905151,"version":"4.3.4"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152043","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T13:47:54Z","timestamp":1459432074000},"page":"e0152043","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia"],"prefix":"10.1371","volume":"11","author":[{"given":"Gilles","family":"Wandeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalo","family":"Musukuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Z\u00fcrcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Vinikoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jara","family":"Llenas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mussa M.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Ehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Hobbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Bolton-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"IeDEA-Southern Africa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"issue":"1 Suppl","key":"ref1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection","volume":"44","author":"MJ Alter","year":"2006","journal-title":"J Hepatol"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/QAD.0b013e32835cb9c8","article-title":"Prevalence of hepatitis B co-infection and response to antiretroviral therapy among HIV-infected patients in Tanzania","volume":"27","author":"C Hawkins","year":"2013","journal-title":"AIDS"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/QAD.0b013e32814e6b08","article-title":"Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B","volume":"21","author":"CJ Hoffmann","year":"2007","journal-title":"AIDS"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/infdis\/jit351","article-title":"Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study","volume":"208","author":"G Wandeler","year":"2013","journal-title":"J Infect Dis"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1016\/j.ijid.2010.06.013","article-title":"Hepatitis B\/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis","volume":"14","author":"RE Barth","year":"2010","journal-title":"International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.aids.0000171404.07995.5c","article-title":"Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate","volume":"19","author":"K Lacombe","year":"2005","journal-title":"AIDS"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/QAD.0b013e32836011c2","article-title":"Tenofovir-based combination therapy for HIV\/HBV co-infection: factors associated with a partial HBV virological response in patients with undetectable HIV viraemia","volume":"27","author":"K Childs","year":"2013","journal-title":"AIDS"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/QAI.0b013e3182a60f7d","article-title":"HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes","volume":"64","author":"RL Hamers","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/cid\/ciu630","article-title":"Hepatitis B Virus Sub-genotype A1 Infection Is Characterized by High Replication Levels and Rapid Emergence of Drug Resistance in HIV-Positive Adults Receiving First-line Antiretroviral Therapy in Malawi","volume":"59","author":"S Aoudjane","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"e0134037","DOI":"10.1371\/journal.pone.0134037","article-title":"Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana","volume":"10","author":"PC Matthews","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"e46345","DOI":"10.1371\/journal.pone.0046345","article-title":"Genotyping and molecular characterization of hepatitis B virus from human immunodeficiency virus-infected individuals in southern Africa","volume":"7","author":"E Makondo","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"e59346","DOI":"10.1371\/journal.pone.0059346","article-title":"Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy","volume":"8","author":"SL Day","year":"2013","journal-title":"PLoS One"},{"key":"ref13","article-title":"Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa","author":"M Egger","year":"2011","journal-title":"Int J Epidemiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcv.2015.08.019","article-title":"Hepatitis B viral load in dried blood spots: A validation study in Zambia","volume":"72","author":"MJ Vinikoor","year":"2015","journal-title":"J Clin Virol"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jviromet.2011.06.009","article-title":"Development and validation of a hepatitis B virus DNA sequencing assay for assessment of antiviral resistance, viral genotype and surface antigen mutation status","volume":"177","author":"MA Mallory","year":"2011","journal-title":"Journal of virological methods"},{"issue":"17","key":"ref16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa051214","article-title":"Variant of hepatitis B virus with primary resistance to adefovir","volume":"354","author":"O Schildgen","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","year":"2009","journal-title":"J Hepatol"},{"key":"ref18","article-title":"Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection","year":"2015"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"CT Wai","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"ref20","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1097\/QAI.0000000000000496","article-title":"Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings","volume":"68","author":"L Stabinski","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0974-777X.83534","article-title":"HIV, Hepatitis B, and Hepatitis C in Zambia","volume":"3","author":"KC Kapembwa","year":"2011","journal-title":"J Glob Infect Dis"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/jmv.21010","article-title":"Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique","volume":"79","author":"L Cunha","year":"2007","journal-title":"J Med Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1471-2334-11-141","article-title":"Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique","volume":"11","author":"J Stokx","year":"2011","journal-title":"BMC infectious diseases"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1086\/605675","article-title":"Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria","volume":"49","author":"J Idoko","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/593104","article-title":"Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program","volume":"47","author":"CJ Hoffmann","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1093\/jac\/dks333","article-title":"Outcomes of starting first-line antiretroviral therapy in hepatitis B virus\/HIV-coinfected patients in Ghana","volume":"67","author":"D Chadwick","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/135965350501000612","article-title":"Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir","volume":"10","author":"J Sheldon","year":"2005","journal-title":"Antivir Ther"},{"issue":"7","key":"ref28","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.00138-06","article-title":"Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus","volume":"50","author":"WEt Delaney","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.22790","article-title":"The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains","volume":"49","author":"S Amini-Bavil-Olyaee","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20723","article-title":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir","volume":"41","author":"MN Brunelle","year":"2005","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S2055-6640(20)30484-2","article-title":"Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries","volume":"1","author":"A Hill","year":"2015","journal-title":"Journal of Virus Eradication"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T16:39:06Z","timestamp":1655397546000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152043"}},"subtitle":[],"editor":[{"given":"Isabelle A","family":"Chemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152043","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}